VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
240 hedge funds and large institutions have $8.22B invested in Verona Pharma in 2025 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 48 increasing their positions, 77 reducing their positions, and 136 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
18% less funds holding
Funds holding: 291 → 240 (-51)
34% less first-time investments, than exits
New positions opened: 90 | Existing positions closed: 136
38% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 77
Holders
240
Holding in Top 10
44
Calls
$77.5M
Puts
$59.8M
Top Buyers
| 1 | +$566M | |
| 2 | +$455M | |
| 3 | +$372M | |
| 4 |
BlackRock
New York
|
+$372M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$349M |
Top Sellers
| 1 | -$547M | |
| 2 | -$532M | |
| 3 | -$387M | |
| 4 |
RI
RTW Investments
New York
|
-$289M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$217M |
